- Symposium brings together industry leaders, investors and
policy decision-makers for two-day event spotlighting the potential
of the Latin American cannabis industry
- CEO and Director Alvaro Torres
and Skin Unit Director Elsa Navarro
to participate in panels covering cannabis investing & finance
and CBD cosmetics topics
- Latin America positioned to be
a vital player in global cannabis industry, valued at an estimated
US$12 Billion within the next decade
(Source Prohibition Partners)
TORONTO, Sept. 26, 2019 /CNW/ - Khiron Life Sciences Corp.
("Khiron" or the "Company") (TSXV: KHRN), (OTCQB: KHRNF),
(Frankfurt: A2JMZC), a vertically
integrated cannabis leader with core operations in Latin America, announced today that the
Company will sponsor and participate in MJBizDaily's first Latin
American Cannabis Symposium taking place September 30 -
October 1 in Bogotá, Colombia. Khiron will be featured prominently
throughout the two-day symposium hosting networking events,
showcases, and participating in panel presentations by key members
of the Company's leadership team.
As Latin America continues to
emerge as one of the world's fastest growing cannabis regions, the
Cannabis Symposium brings together global industry leaders,
investors, innovators and policy decision-makers for an intensive
two-day discussion and networking event covering insights on
industry standards, government policy and research, as well as
emerging investment and business opportunities in the Latin
American and Caribbean cannabis
markets.
"Khiron firmly believes that Latin
America will be a vital player in the global cannabis
industry of the future. Since the beginning, we have worked
actively through our education programs, first-to-market branded
clinics and products and industry events to drive forward the
growth of the region's cannabis industry," commented Alvaro Torres, CEO and Director of Khiron Life
Sciences. "We welcome the industry gathering in Bogota for this symposium and look forward to
discussing the fast developing Latin American cannabis sector."
In conversation with industry leaders and experts, the Company
leadership team will also participate in the conference's agenda of
panel discussions, including:
- Alvaro Torres, CEO and Director,
Khiron Life Sciences
Panel: Investing and Finance Forum, Attracting International
Investors
September 30th,
1:00 to 1:30 PM, Grand Ballroom III,
Grand Hyatt Bogotá
- Elsa Navarro, Skin Unit
Director, Khiron Life Sciences
Panel: Production to Distribution Insights, Behind the Scenes:
Cannabis Cosmetics and the Infused Products Market
October 1st, 1:20 to 2:00 PM, Grand Ballroom III, Grand Hyatt
Bogotá
In collaboration with MJBizDaily, Khiron will also host an
exclusive cocktail reception on September
30 from 5-7 pm. Attendees will
have the opportunity to explore opportunities in the Latin American
cannabis industry, learn more on Khiron's market-leading products
and services, and network with key industry players and
decision-makers.
About Khiron Life Sciences Corp.
Khiron Life Sciences
Corp. is positioned to be the dominant integrated cannabis company
in Latin America. Khiron has core
operations in Latin America and is
fully licensed in Colombia for the
cultivation, production, domestic distribution, and international
export of both tetrahydrocannabinol (THC) and cannabidiol (CBD)
medical cannabis. The company delivers best in class regulatory
compliance, has the first approved set of CBD cosmetic products on
shelf in Colombia, and is currently facilitating testing to
meet and surpass all license requirements for commercial cannabis
derived products.
With a focused regional strategy and patient oriented
approach, the Company combines global scientific expertise,
agricultural advantages, branded product market entrance
experience and education to drive prescription and brand
loyalty to address priority medical conditions such as chronic
pain, epilepsy, depression and anxiety in the Latin American
market of over 620 million people. The Company is led by Co-founder
and Chief Executive Officer, Alvaro
Torres, together with an experienced executive team,
and a knowledgeable Board of Directors that includes former
President of Mexico, Vicente Fox.
Cautionary Notes
Forward-Looking Statements
This press release may contain certain "forward-looking
information" and "forward-looking statements" within the meaning of
applicable securities legislation. All information contained herein
that is not historical in nature may constitute forward-looking
information. Khiron undertakes no obligation to comment analyses,
expectations or statements made by third-parties in respect of
Khiron, its securities, or financial or operating results (as
applicable). Although Khiron believes that the expectations
reflected in forward-looking statements in this press release are
reasonable, such forward-looking statement has been based on
expectations, factors and assumptions concerning future events
which may prove to be inaccurate and are subject to numerous risks
and uncertainties, certain of which are beyond Khiron's control,
including the risk factors discussed in Khiron's Annual Information
Form which is available on Khiron's SEDAR profile
at www.sedar.com. The forward-looking information contained in
this press release is expressly qualified by this cautionary
statement and are made as of the date hereof. Khiron disclaims any
intention and has no obligation or responsibility, except as
required by law, to update or revise any forward-looking
information, whether as a result of new information, future events
or otherwise.
United States Disclaimer
This news release does not constitute an offer to sell or a
solicitation of an offer to buy any of the securities
in the United States. The securities have not been and
will not be registered under the United States Securities Act of
1933, as amended (the "U.S. Securities Act") or any state
securities laws and may not be offered or sold within the
United States or to U.S. Persons
(as such term is defined in Regulation S under the U.S. Securities
Act) unless registered under the U.S. Securities Act and applicable
state securities laws or an exemption from such registration is
available
Neither the TSXV nor its Regulation Services Provider (as
that term is defined in the policies of the TSXV) accepts
responsibility for the adequacy or accuracy of this press
release.
Further information in respect of the Company can be found
at www.khiron.ca.
View original content to download
multimedia:http://www.prnewswire.com/news-releases/khiron-to-present-and-host-attendees-at-first-mjbizdaily-latin-american-cannabis-symposium-300925718.html
SOURCE Khiron Life Sciences Corp.